The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 15, 2005
Filed:
Sep. 19, 2003
Rainer Walter, Biberach, DE;
Wolfgang Grell, Biberach, DE;
Armin Heckel, Biberach, DE;
Frank Himmelsbach, Mittelbiberach, DE;
Wolfgang Eberlein, Biberach, DE;
Gerald Roth, Biberach, DE;
Jacobus C.a. Van Meel, Moedling, AT;
Norbert Redemann, Biberach, DE;
Walter Spevak, Oberrohrbach, AT;
Ulrike Tontsch-grunt, Baden, AT;
Thomas Von Rueden, Planegg, DE;
Rainer Walter, Biberach, DE;
Wolfgang Grell, Biberach, DE;
Armin Heckel, Biberach, DE;
Frank Himmelsbach, Mittelbiberach, DE;
Wolfgang Eberlein, Biberach, DE;
Gerald Roth, Biberach, DE;
Jacobus C.A. van Meel, Moedling, AT;
Norbert Redemann, Biberach, DE;
Walter Spevak, Oberrohrbach, AT;
Ulrike Tontsch-Grunt, Baden, AT;
Thomas von Rueden, Planegg, DE;
Boehringer Ingelheim Pharma KG, Ingelheim, DE;
Abstract
The present invention relates to new substituted indolinones of general formulawherein The above compounds of general formula I wherein Rdenotes a hydrogen atom, a C-alkyl group or a prodrug group have valuable pharmacological properties, particularly an inhibiting effect on various kinases, on viral cyclin and on receptor tyrosine kinases, and the other compounds of the above general formula I wherein Rdoes not represent a hydrogen atom, a C-alkyl group or a prodrug group are valuable intermediate products for the preparation of the abovementioned compounds.